# Butylphthalide for Cognitive Impairment in Elderly Patients With Focal Epilepsy

> **NCT07193277** · PHASE4 · RECRUITING · sponsor: **First Affiliated Hospital of Wenzhou Medical University** · enrollment: 220 (estimated)

## Conditions studied

- Focal Epilepsy
- Cognitive Impairment

## Interventions

- **DRUG:** Butylphthalide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07193277
- **Lead sponsor:** First Affiliated Hospital of Wenzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-09-01
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2025-09-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07193277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07193277, "Butylphthalide for Cognitive Impairment in Elderly Patients With Focal Epilepsy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07193277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*